Placeholder Image

字幕列表 影片播放

  • - We are announcing our plan to stay ahead of this virus

  • by being prepared to offer COVID-19 booster shots

  • to fully vaccinated adults 18 years and older.

  • They would be eligible for their booster shot

  • eight months after receiving their second dose

  • of the Pfizer or Moderna mRNA vaccines.

  • We plan to start this program

  • the week of September 20th, 2021.

  • - [Narrator] The Biden administration booster announcement

  • comes amid reports of fully vaccinated people getting COVID,

  • cases known as breakthrough infections.

  • This includes a Wall Street Journal analysis

  • that found the Delta variant is breaking through

  • vaccine protection at a higher rate than other strains.

  • - I wanna be very clear.

  • This plan is pending the FDA conducting

  • an independent evaluation of the safety and effectiveness

  • of a third dose of the Pfizer and Moderna mRNA vaccines

  • and the CDC's advisory committee on immunization practices

  • issuing booster dose recommendations

  • based on a thorough review of the evidence.

  • - [Narrator] Here's why a third-dose booster shot

  • of mRNA vaccines is now recommended

  • for fully vaccinated people.

  • (bell dinging)

  • Data suggests that while vaccines are still shown

  • to be highly effective,

  • as antibodies begin to dwindle naturally,

  • the protection vaccines offer it can wane over time.

  • The mRNA boosters that the Biden administration

  • is recommending could have a big impact.

  • Studies show that they generate higher levels

  • of neutralizing antibodies than just two doses alone.

  • Neutralizing antibodies are the ones primarily responsible

  • for stopping the virus from entering cells.

  • - Antibodies are seen as providing

  • some of that initial protection against the virus,

  • potentially stopping infection from happening

  • and from the virus from spreading.

  • The reason why we are seeing vaccines still hold up

  • and be effective at preventing hospitalization

  • or severe disease or death

  • is because of other parts of the immune system,

  • what's known as the adaptive immune system,

  • such as T cells or memory B cells.

  • T cells actually identify, seek out,

  • and destroy the infected cells.

  • - [Narrator] The mRNA vaccine makers have released data

  • showing that antibody levels have increased

  • following booster shots,

  • and Pfizer and partner BioNTech are planning

  • to seek clearance from the FDA for a COVID-19 booster

  • for the general population.

  • The company said they sent the FDA results

  • from a small early stage studies

  • showing a third dose of vaccines generated higher levels

  • of neutralizing antibodies against the original virus,

  • as well as the Beta and Delta variants.

  • The third dose appeared safe in the trial as well.

  • The Biden administration is recommending that booster shots

  • for the general public be taken about eight months

  • after the second dose of mRNA vaccines.

  • But for some who are immunocompromised

  • and don't have a strong immune response

  • to the standard two-course vaccine regimen,

  • booster shots could be needed even sooner.

  • The current guidance in the CDC is that those

  • who are moderately to severely immunocompromised

  • should take a third dose of an mRNA vaccine

  • at least 28 days after the second shot.

  • - Immunocompromised people is a very broad term

  • that includes people who are transplant patients,

  • so if you have a kidney transplant.

  • It can include some cancer patients.

  • Basically individuals whose immune systems

  • don't necessarily respond like the general populations.

  • - [Narrator] Some of those who fall into this category

  • should be able to walk into certain clinics

  • to get a booster shot now,

  • but for the general population,

  • boosters have not yet been approved by the FDA,

  • which gives final approval on vaccines.

  • Pfizer is the furthest along

  • in the regulatory approval process,

  • but Moderna, which also produces a two-dose mRNA vaccine,

  • said it plans to ask regulators next month

  • to authorize booster shots as well.

  • - The plan ensures that people who were fully vaccinated

  • earliest in the vaccination rollout

  • will be eligible for a booster first.

  • This includes our most vulnerable populations,

  • like our healthcare providers, nursing home residents,

  • and other seniors.

  • - [Narrator] Johnson & Johnson does not make

  • an mRNA vaccine,

  • which means the current booster guidelines won't apply.

  • - For people who received the Johnson & Johnson vaccine,

  • we anticipate vaccine boosters will likely be needed.

  • The J & J vaccine was not administered in the U.S.

  • until March of 2021,

  • and we expect more data on J & J in the coming weeks.

  • - [Narrator] The company's expected to release data

  • about the efficacy of two doses of its single-shot vaccine

  • later this month.

  • The White House has said that it is prepared

  • with enough extra vaccine orders

  • if the FDA approves the booster.

  • - That is why we ordered the number of doses we did order

  • several months ago because we are like boy scouts

  • and girl scouts and always wanna be prepared.

  • (bell dinging)

- We are announcing our plan to stay ahead of this virus

字幕與單字

單字即點即查 點擊單字可以查詢單字解釋

B2 中高級 美國腔

Covid-19 Boosters Are Coming(Covid-19 Boosters Are Coming: Here’s What to Know | WSJ)

  • 63 4
    moge0072008 發佈於 2021 年 08 月 21 日
影片單字